19
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Steroid Biosynthetic Enzymes: 17 β Hydroxysteroid Dehydrogenase

, , , , &
Pages 91-97 | Published online: 08 Jul 2009

References

  • Tseng L, Gurpide E. Estradiol and 20α-dihydroprogesterone activity in human endometrium during the menstrual cycle. Endocrinology 1974; 94: 419–23
  • Pollow K, Lubbert H, Boquoi E, Kreuzer G, Jeske R, Follow B. Studies on 17 β-hydroxysteroid dehydrogenase in human endometrium and endometrial carcinoma. Acta Endocrinol 1975; 79: 134–45
  • Tseng L. Hormonal regulation of steroid metabolic enzymes in human endometrium. Advances in sex steroid hormone research., J A. Thomas, R L. Singhal. Urban & amp; Schwarzenberg, Baltimore 1980; 329–61
  • Neumannova M, Kauppila A, Kivinen S, Vihko R. Shortterm effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 β-hydroxysteroid dehydrogenase in human endometrium. Obstet Gynecol 1985; 66: 695–700
  • Kokko E, Jänne O, Kauppila A, Vihko R. Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17 β-hydroxysteroid dehydrogenase activity, and serum hormone concentrations. Am J Obstet Gynecol 1982; 143: 382–8
  • Vihko R, Isotalo H, Kauppila A, Rönnberg L, Vierikko P. Hormonal regulation of endometrium and endometriosis tissue. Medical management of endometriosis., J P. Raynaud, T Ojasoo, L Martini. Raven Press, New York 1984; 79–89
  • Tseng L, Gurpide E. Changes in vitro, metabolism of estradiol by human endometrium during the menstrual cycle. Am J Obstet Gynecol 1972; 114: 1002–8
  • Pons M, Nicolas S C., Bossioux A M., Descomps B, Van den De Paulet A. Some new developments in the knowledge of human placental estradiol-17 β dehydrogenase. J Steroid Biochem 1977; 8: 345–58
  • Mäentausta O, Peltoketo H, Isomaa V, Jouppila P, Vihko R. immunological measurement of human 17β-hydroxysteroid dehydrogenase. J Steroid Biochem 1990; 36: 673–80
  • Mäentausta O, Sormunen R, Isomaa V, Lento V P., Jouppila P, Vihko R. Immunohistochemical localization of 17β-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle. Lab Invest 1991; 65: 582–7
  • Mäentausta O, Menjlvar M, Vihko R. Time-resolved immunofluorometric assay of 17β-hydroxysteroid dehydrogenase in plasma. Clin Chem 1991; 37: 1412–15
  • Peltoketo H, Isomaa V, Mäentausta O, Vihko R. Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 1988; 239: 73–7
  • Luu The V, Labrie C, Zhao H F., et al. Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5'-termini in human placenta. Mol Endocrinol 1989; 3: 1301–9
  • Gast M J., Sims H F., Murdock G L., Gast P M., Strauss A W. Isolation and sequencing of a cDNA clone encoding human placental 17β-estradiol dehydrogenase: identification of the putative cofactor binding site. Am J Obstet Gynecol 1989; 161: 1726–31
  • Scubllnsky A, Marin C, Gurplde E. Localization of estradiol 17β-dehydrogenase in human endometrium. J Steroid Biochem 1976; 7: 745–7
  • Hollnka C F., Gurplde E. Hormone-related enzymatic activities in normal and cancer cells of human endometrium. J Steroid Biochem 1981; 15: 183–92
  • Kauppila A, Isotalo H, Kivinen S, Stenbäck F, Vihko R. Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17β-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma. Int J Cancer 1985; 35: 157–63
  • Kauppila A JI, Isotalo H E., Kivinen S T., Vihko R K. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer. Cancer Res 1986; 46: 5380–4
  • Mäentausta O, Boman K, Isomaa V, Stendahl U, Bäckström T, Vihko R. Immunohistochemical study of the human 17β-hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma. Cancer 1992; 70: 1551–5
  • Pollow K, Boquol E, Baumann J, Schmidt-Gollwltzer M, Pollow B. Comparison of the in vitro conversion of estradiols 7β to estrone of normal and neoplastic human breast tissue. Mol Cell Endocrinol 1977; 6: 333–48
  • Gompel A, Malet C, Spritzer P, Lalardrie J P., Kuttenn F, Mauvais-Jarvis P. Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 1986; 63: 1174–80
  • Fournier S, Kuttenn F, de Clcco F, Baudot N, Malet C, Mauvais-Jarvis P. Estradiol 17β-hydroxysteroid dehydrogenase activity in human breast fibroadenomas. J Clin Endocrinol Metab 1982; 55: 428–33
  • Bonney R C., Reed M J., Davison K, Beraneck P A., James V HT. The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin Endocrinol 1983; 19: 727–39
  • Adams J B., Phillips N S., Pewnim T. Expression of hydroxysteroid sulphotransferase is related to estrogen receptor status in human mammary cancer. J Steroid Biochem 1989; 33: 637–42
  • Talt G H., Newton C J., Reed M J., James V HT. Multiple forms of 17β-hydroxysteroid oxidoreductase in human breast tissue. J Mol Endocrinol 1989; 2: 71–80
  • Milewlch L, Carr B R., Frenkel R A., Marrero M, Macdonald P C., Mason Jl. 17β-Hydroxysteroid oxidoreductases of human fetal and adult tissues: Immunological cross-reactivity with an anti-human placental cytosolic 17β-hydroxysteroid oxidoreductase antibody. Placenta 1990; 11: 95–108
  • Poutanen M, Isomaa V, Lehto V P., Vihko R. Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 1992; 50: 386–90
  • Poutanen M, Moncharmont B, Vihko R. 17β-Hydroxysteroid dehydrogenase gene expression in human breast cancer cells: Regulation of the expression by a progestin. Cancer Res 1992; 52: 290–4
  • Vermeulen A, Deslypere J P., Paridaens R, Leclercq G, Roy F, Heuson J C. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular tissue in postmenopausal women. Eur J Cancer Clin Oncol 1986; 22: 515–25
  • Leszczynskl D, Santner S J., Fell P D., Santen R J. 17β-hydroxysteroid, dehydrogenase in human breast cancer: analysis of kinetic and clinical parameters. Steroids 1988; 51: 299–316
  • Fournier S, Brlhmat F, Sterkers N, Martin P M., Van den Mauvais F., Jarvis P. Estradiol 17β-hydroxysteroid dehydrogenase, a marker of breast cancer hormone dependency. Cancer Res 1985; 45: 2895–9
  • Adams E F., Goldham N G., James V TH. Steroidal regulation of oestradiol-17β dehydrogenase activity of the human breast cancer cell line MCF-7. J Endocrinol 1988; 118: 149–54
  • Poutanen M, Isomaa V, Kainulainen K, Vihko R. Progestin induction of 17β-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast cancer cell line. Int J Cancer 1990; 46: 897–901
  • Therlault C, Poulin R, Tremblay S, Poirier D, Labrie F. Hormonal regulation of estradiol 17β-hydroxysteroid dehydrogenase activity in the ZR-75-1 human breast cancer cell line. Ann NYAcadSci 1990; 595: 419–21
  • Sigh A, Reed M J. Insulin-like growth factor type I and insulin-like growth factor type II stimulate oestradiol-17β hydroxysteroid dehydrogenase (reductive) activity in breast cancer cells. J Endocrinol 1991; 129: R5–8
  • Adams E F., Rafferty B, White M C. Interleukin 6 is secreted by breast fibroblasts and stimulates 17β-oestradiol oxidoreductase activity of MCF-7 cells: possible paracrine regulation of breast 17β-oestradiol levels. Int J Cancer 1991; 49: 118–21
  • Sigh A, Reed M J., Ghllchlk M W., James V HT. The effect of breast tumour and normal breast tissue cytosols on oestra-diol-17β hydroxysteroid dehydrogenase activity. Cancer Lett 1989; 44: 45–8
  • Adams E F., Newton C J., Braunsberg H, Shaikh N, Ghllchlk M, James V HT. Effects of human breast fibroblasts on growth and 17β-estradiol dehydrogenase activity of MCF-7 cells in culture. Breast Cancer Res Treatment 1988; 11: 165–72
  • McNeill J M., Reed M J., Beraneck P A., et al. A comparison of the in vivo uptake and metabolism of [3H] oestrone and [3H] oestradiol by normal breast and breast tumour tissues in postmenopausal women. Int J Cancer 1986; 15: 193–6
  • Tremblay Y, Ringler G E., Morel Y, et al. Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cenq25. J Biol Chem 1989; 264: 20458–62
  • Winqvlst R, Peltoketo H, Isomaa V, Van den Mannermaa A, Vihko R. The gene for 17beta-hydroxy-steroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows and RFLP with Seal. Hum Genet 1990; 85: 473–6
  • Hall J M., Lee M K., Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–9
  • Luu The V, Labrie C, Simard J, et al. Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes. Mol Endocrinol 1990; 4: 268–75
  • Breathnach R, Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem 1981; 50: 349–83
  • Paolella G, Lucero M A., Murphy H M., Baralle F E. The Alu family repeat promoter has a tRNA-like bipartite structure. EMBO J 1983; 3: 691–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.